February 11, 2011
Gabapentin, Depomed, inc. (NASDAQ: DEPO) announced today that its phase 1 of the second pharmacokinetic-pharmacodynamic study in patients with Parkinson’s, MD-1992, Depomed’s novel investigation of the stomach retention, the sustained release formulation of levodopa / carbidopa, has maintained therapeutic blood levels of levodopa for 24 hours in a twice-daily formulation. Two separate formulations twice daily [...]
Read the full article →
February 11, 2011
It’s the middle of winter and you are under attack by a silentenemy that invades your nose, throat and lungs, reducing you to asneezing, sniffling and aching mess. Yes, the flu season is here again, ready to strike our bodiesand make us feel miserable for days or even weeks.according toCenters for Disease Control and Prevention, [...]
Read the full article →